EMPA-KIDNEY study
123,000
Views
100k 340
This medical educational webinar is intended for healthcare professionals
only to communicate clinical trial updates in the EMPOWER program, including the EMPA-KIDNEY
trial. Empagliflozin is currently not indicated for the treatment of chronic kidney disease.
Please refer to the local product information for the current indication in your country.
SC-SG-01327